Products

Gastrophage polyvalent MediPhag

Composition of the preparation:
A mixture of sterile filtrates of phagolysates of bacteria:
S.Typhimurium; S. Newport; S. Enteritidis; S. Moscow; S. Paratyphi B; S. Agama;
and S. Java - pathogens of salmonellosis. Sh.flexneri serovarov I, II, III, VI; Sh.sonnei and Sh. boydii - causative agents of dysentery. Proteus, Staphylococcus aureus,
Pseudomonas aeruginosa, Escherichia coli, the most significant in the etiology of 6
enteral diseases. The phage titer is not less than 10 CFU/ml.

Bacteriophage salmonella polyvalent
Salmonella polyvalent bacteriophage "MediPhag" is used for the treatment and prevention of salmonellosis caused by S.Typhimurium S. Newport; S.Enteritidis; S.Moscow; S.Pharatyphi B; S.Agama; and S.Java .
--treatment of patients diagnosed with acute diarrhea (gastritis, gastroenteritis, gastroenterocolitis, enteritis, enterocolitis, colitis) and salmonellosis, in all age and high-risk groups;
therapy
Бактериофаг стафилококковый жидкий “MediPhag” 
Staphylococcal bacteriophage in the form of a spray is used for therapeutic and prophylactic purposes in the form of irrigation, infected with staphylococcus skin and mucous membranes for burns, purulent-inflammatory diseases, infected wounds, and angina. According to the doctor's decision, you can use the Bacteriophage staphylococcal liquid “MediPhag" during pregnancy.

therapy
Bacteriophage dysentery polyvalent “MediPhag”
– in the form of a gelatin capsule of white color
Bacteriophage dysentery polyvalent “MediPhag" – in the form of a gelatin capsule of white color No. 0, containing lyophilized beige powder. Bacteriophage capsules are recommended for patients with dysentery who are over 3 years old. The use of the drug "Bacteriophage dysentery polyvalent "MediPhag"" does not cancel the use of other drugs intended for the treatment of dysentery. By the decision of the doctor, you can use the drug "Bacteriophage dysentery polyvalent "MediPhag"" during pregnancy.

therapy
Bacteriophage staphylococcal liquid “MediPhag" instructions
Bacteriophage staphylococcal liquid “MediPhag” is used for the treatment and prevention of bacterial purulent–inflammatory diseases caused by Staphylococcus aureus in all age and high-risk groups.
Treatment:
Surgical infections: purulent wound, burn, abscess, phlegmon,
therapy

Treatment and prevention

diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy)

surgical infections (suppuration of wounds, burns abscess, phlegmon, boils, carbuncles,
hydradenitis, panaritium, paraproctitis, mastitis, bursitis,
osteomyelitis; generalized septic diseases)

urogenital infections
(urethritis, cystitis, pyelonephritis, colpitis,
endometritis, salpingoophoritis)

enteral infections (gastroenterocolitis, cholecystitis, intestinal dysbiosis)

purulent-inflammatory diseases of newborns (omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.)

Treatment of stomatitis and chronic generalized periodontitis

L

Treatment and prevention

It is used for th e treatment and prevention of bacterial dysentery caused by Sh.flexneri serovars I,II,III, and VI types and Sh.sonnei: -treatment of patients diagnosed with acute diarrhea with colitic syndrome and bacterial dysentery in all age and high-risk groups;

-rehabilitation of convalescents (bacteriocarriage);

- prevention. Phaging with dysentery bacteriophage is carried out among children and service personnel in preschool institutions, schools and health camps, during the seasonal rise in morbidity. The optimal scheme of use is a daily intake of 10 to 40 ml or 1-2 capsules depending on age (as well as for treatment purposes). The duration of taking the drug is determined by the conditions of the epidsituation

Address

Uzbekistan, Tashkent, Yunusabad district, 17th quarter, Industrial zone, Northern part of section No.2


Contacts

+99890 175-46-16
+99895 170-46-16
Email:aziyaimmunopreparat@mail.ru

About us
    LLC "Aziya immunopreparat" was established in 2014. Has a license for pharmaceutical activity No. P5073. The main activities of LLC "Aziya immunopreparat" are the development, production and sale of immunobiological drugs, in particular bacteriophages.
 

 

© Copyright 2025 Aziya Immunopreparat